As of publication, stocks related to the AI medical concept have exhibited significant volatility and decline. Notably, Hycrea Pharma saw a drop of over 10%, while Yifang Biology and Hotgen Biotech experienced declines exceeding 5%. Other stocks, including Shiyao Holding, Auscope Endoscopy, and Hybio, also fell in tandem.
